ZLABMID

Zai Lab Limited

HealthcareBiotechnology
$19.35
$0.00(+1.42%)
52W$15.96
$41.20
Updated Jul 8, 02:00 AM
RSI57
RS Rating30/99
Beta1.05
Volatility52%
F-Score3/9
Mkt Cap$2.1B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Zai Lab Limited is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 30), showing significant lag compared to the market leaders. Earnings contraction of 11% provides fundamental context to the price action. Investors should exercise caution due to high volatility (52% annualized), which requires wider risk management.

Relative Strength
30
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.05
vs S&P 500
MARKET
52W Position
13%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$18.96
50 SMA > 100 SMA$19.45
100 SMA > 150 SMA$19.03
150 SMA > 200 SMA$21.12

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$18.13+6.73%ABOVE
50 SMA$18.96+2.08%ABOVE
100 SMA$19.45-0.54%BELOW
150 SMA$19.03+1.67%ABOVE
200 SMA$21.12-8.38%BELOW

Price Performance

1D+1.4%
1W+1.8%
1M+17.4%
3M-7.9%
6M+1.7%
YTD+11.7%
1Y-45.5%
3Y-12.6%
52-Week Trading Range13% from low
$19.35
52W Low$15.96
52W High$41.20

Technical Indicators

RSI (14)NEUTRAL
57.5
305070
Setup ScoreCOOL
5/10
Base depth: 46.6%

Risk Profile

Beta
1.05
52W Vol
52%
ATR
$0.73
Max DD (1Y)
-60%

Volume Analysis

Today
595.8K
50D Avg
826.3K
Vol Ratio
0.72x
Liquidity
MODERATE

Earnings Momentum

Q2'25+95%
$-0.37
Q3'25+92%
$-0.33
Q4'25+43%
$-0.46
Q1'26-11%
$-0.50
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+56.54%
3 Years:+28.86%
TTM:+8.36%

Compounded Profit Growth

10 Years:+22.59%
5 Years:
3 Years:
TTM:+87.93%

Stock Price CAGR

10 Years:-3.60%
5 Years:-35.04%
3 Years:-12.59%
1 Year:-45.46%

Return on Equity

10Y Avg:-44.7%
5Y Avg:-36.4%
3Y Avg:-30.1%
Last Year:-24.3%

Key Metrics

Market Cap$2.1B
Gross Margin58.5%
Net Margin-38.1%
Piotroski F-Score3/9

Frequently Asked Questions

Is ZLAB in an uptrend right now?

ZLAB has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ZLAB overbought or oversold?

ZLAB's RSI (14) is 57. The stock is in neutral territory, neither overbought nor oversold.

Is ZLAB outperforming the market?

ZLAB has a Relative Strength (RS) Rating of 30 out of 99. ZLAB is currently lagging the broader market.

Where is ZLAB in its 52-week range?

ZLAB is trading at $19.35, which is 47% of its 52-week high ($41.20) and 13% above its 52-week low ($15.96).

How volatile is ZLAB?

ZLAB has a Beta of 1.05 and 52-week volatility of 52%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.